GE HealthCare Technologies Inc. $GEHC Shares Sold by Public Employees Retirement System of Ohio

Public Employees Retirement System of Ohio cut its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 31.3% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 162,267 shares of the company’s stock after selling 74,058 shares during the quarter. Public Employees Retirement System of Ohio’s holdings in GE HealthCare Technologies were worth $11,550,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of GEHC. Vanguard Group Inc. raised its position in shares of GE HealthCare Technologies by 0.5% during the fourth quarter. Vanguard Group Inc. now owns 52,275,767 shares of the company’s stock worth $4,287,658,000 after purchasing an additional 267,058 shares during the period. Auto Owners Insurance Co boosted its position in shares of GE HealthCare Technologies by 9,525.4% in the 4th quarter. Auto Owners Insurance Co now owns 33,982,610 shares of the company’s stock valued at $278,725,000 after purchasing an additional 33,629,559 shares during the period. Dodge & Cox increased its stake in GE HealthCare Technologies by 13.4% in the 4th quarter. Dodge & Cox now owns 31,211,229 shares of the company’s stock worth $2,559,945,000 after purchasing an additional 3,693,918 shares in the last quarter. Capital Research Global Investors increased its stake in GE HealthCare Technologies by 1.6% in the 4th quarter. Capital Research Global Investors now owns 25,362,352 shares of the company’s stock worth $2,080,248,000 after purchasing an additional 389,796 shares in the last quarter. Finally, State Street Corp raised its holdings in GE HealthCare Technologies by 2.0% during the 4th quarter. State Street Corp now owns 20,049,677 shares of the company’s stock worth $1,644,475,000 after buying an additional 401,932 shares during the period. 82.06% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research firms have commented on GEHC. Evercore set a $80.00 price objective on shares of GE HealthCare Technologies in a research note on Thursday, April 30th. Rothschild & Co Redburn dropped their target price on shares of GE HealthCare Technologies from $110.00 to $98.00 in a research report on Thursday, April 30th. BMO Capital Markets started coverage on shares of GE HealthCare Technologies in a report on Wednesday, July 8th. They set a “market perform” rating and a $70.00 price target on the stock. Argus reduced their price target on shares of GE HealthCare Technologies from $95.00 to $80.00 and set a “buy” rating for the company in a research report on Tuesday, May 19th. Finally, Jefferies Financial Group decreased their price objective on shares of GE HealthCare Technologies from $105.00 to $90.00 in a research note on Thursday, April 30th. Ten research analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and an average price target of $76.41.

GE HealthCare Technologies Stock Performance

NASDAQ:GEHC opened at $60.58 on Monday. The stock has a market cap of $27.56 billion, a PE ratio of 14.49, a price-to-earnings-growth ratio of 1.65 and a beta of 0.72. GE HealthCare Technologies Inc. has a fifty-two week low of $58.75 and a fifty-two week high of $89.77. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.22 and a quick ratio of 0.95. The stock’s 50-day moving average is $63.63 and its two-hundred day moving average is $71.14.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). The company had revenue of $5.13 billion during the quarter, compared to analysts’ expectations of $5.04 billion. GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.GE HealthCare Technologies’s revenue for the quarter was up 7.4% compared to the same quarter last year. During the same period last year, the company earned $1.01 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, equities research analysts forecast that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Friday, July 24th will be given a $0.035 dividend. The ex-dividend date is Friday, July 24th. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is presently 3.35%.

Insider Activity

In other news, Director Kevin Lobo purchased 10,000 shares of GE HealthCare Technologies stock in a transaction dated Friday, May 22nd. The stock was acquired at an average cost of $64.18 per share, for a total transaction of $641,800.00. Following the acquisition, the director directly owned 14,363 shares in the company, valued at $921,817.34. This represents a 229.20% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Rodney F. Hochman bought 1,618 shares of the business’s stock in a transaction on Tuesday, May 12th. The shares were bought at an average price of $62.03 per share, for a total transaction of $100,364.54. Following the completion of the acquisition, the director owned 1,618 shares of the company’s stock, valued at approximately $100,364.54. This represents a ∞ increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. In the last quarter, insiders have acquired 21,847 shares of company stock valued at $1,361,355. 0.36% of the stock is currently owned by company insiders.

GE HealthCare Technologies News Summary

Here are the key news stories impacting GE HealthCare Technologies this week:

• Positive Sentiment: GE HealthCare reported preliminary second-quarter 2026 results and reaffirmed its full-year guidance, which suggests the business is still tracking in line with expectations and may be seeing momentum in key areas. GE HealthCare announces CFO transition; reports preliminary second quarter 2026 financial results and reaffirms guidance reflecting business momentum
• Positive Sentiment: The company’s revenue outlook appears steady, with Q2 revenue guidance roughly in line with Wall Street estimates, and management has indicated that second-half performance could improve as cost pressures ease. Can GE HealthCare Sustain Growth in Q2 Amid Persistent Cost Headwinds?
• Neutral Sentiment: GE HealthCare announced that CFO Jay Saccaro will step down, but the company framed the move as a transition rather than a crisis, which makes the near-term market impact uncertain. GE HealthCare CFO to step down
• Negative Sentiment: Ongoing securities-fraud investigations and shareholder-loss solicitations add legal uncertainty and can weigh on sentiment toward GEHC stock. GE HealthCare Technologies Inc. (GEHC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
• Negative Sentiment: Another law firm expanded a securities-fraud probe tied to prior disclosures, reinforcing investor concerns about possible litigation risk. Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
• Negative Sentiment: GE HealthCare was downgraded by Zacks Research from “hold” to “strong sell,” which may add to selling pressure. Zacks Research downgrade

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.